Table 2 Main characteristics of participants interviewed for Rasch analysis
Characteristic | Description |
|---|---|
Sexa [n(%)] | |
Men | 104 (64.20%) |
Women | 58 (35.80%) |
Age [Mean (SD)] | 61 (15) |
Charlson index [Mean (SD)] | 3.26 (2.43) |
Karnofsky index [Mean (SD)] | 70.41 (16.99) |
Main disease [n(%)] | |
Oncologic | 93 (56.36%) |
Neurological | 31 (18.79%) |
Malabsorption | 41 (24.85%) |
HEN duration [n(%)] | |
1-3 months | 59 (35.76%) |
4-6 months | 34 (20.61%) |
7-9 months | 15 (9.09%) |
10-12 months | 15 (9.09%) |
More than 12 months | 42 (25.45%) |
HEN function [n(%)] | |
Sole source of nutrition | 105 (63.64%) |
Nutritional supplement | 60 (36.36%) |
Administration route [n(%)] | |
Oral | 92 (55.76%) |
Ostomy | 50 (30.30%) |
Nasogastric tube | 17 (10.30%) |
Oral and ostomy | 4 (2.42%) |
Oral and nasogastric tube | 1 (0.61%) |
Nasogastric tube and ostomy | 1 (0.61%) |